SCHEMBL21647261

SCHEMBL21647261

CC(C)Cc1cc(C#N)ccc1N

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 1/20 0.38
SLC6A4 P31645 1/20 0.38
SLC6A3 Q01959 1/20 0.38
HRH4 Q9H3N8 1/20 0.37
ALDH1A1 P00352 3/20 0.37
POLB P06746 1/20 0.37
MAPT P10636 1/20 0.37
KDM4E B2RXH2 1/20 0.36
GAA P10253 1/20 0.36
ABCC9 O60706 1/20 0.35
ABCC8 Q09428 1/20 0.35
KCNJ11 Q14654 1/20 0.35
KCNJ8 Q15842 1/20 0.35
CYP2A6 P11509 2/20 0.34
LOXL2 Q9Y4K0 1/20 0.34
GLA P06280 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
TSHR P16473 1/20 0.34
MAPK1 P28482 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18398468 0.82 ALDH1A1 (0.36) SLC6A2SLC6A4SLC6A3HRH4ALDH1A1
SCHEMBL14498203 0.80 CYP2A6 (0.39) SLC6A4SLC6A3ALDH1A1KDM4EGAA
SCHEMBL398911 0.79 ALDH1A1 (0.56) SLC6A2SLC6A4SLC6A3HRH4ALDH1A1
SCHEMBL7927295 0.79 TTR (0.33) HRH4ALDH1A1POLBKDM4EGLA
SCHEMBL12550188 0.79 MPO (0.41) SLC6A2SLC6A4SLC6A3ALDH1A1POLB
SCHEMBL4771536 0.79 GABRA1 (0.58) SLC6A2SLC6A3ALDH1A1POLBMAPT
SCHEMBL14087100 0.79 MPO (0.40) SLC6A4SLC6A3GAAABCC9ABCC8
SCHEMBL14485255 0.79 ABCC9 (0.35) SLC6A4SLC6A3HRH4ALDH1A1ABCC9
SCHEMBL23998922 0.77 PSEN1 (0.37) SLC6A4SLC6A3ALDH1A1ABCC9ABCC8
SCHEMBL3027085 0.76 S1PR1 (0.37) ALDH1A1CYP2A6LOXL2GLATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12563960-B2 Organic compound, light-emitting device, light-emitting apparatus, electronic device, and lighting device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2026-02-24 US disclosed
CN-120192350-A Organic compound, light-emitting element, light-emitting device, electronic device, and lighting device 株式会社半导体能源研究所 2025-06-24 CN disclosed
CN-112673013-B Organic compound, light-emitting element, light-emitting device, electronic device, and lighting device 株式会社半导体能源研究所 2025-04-18 CN disclosed
US-20210336156-A1 Organic Compound, Light-Emitting Device, Light-Emitting Apparatus, Electronic Device, and Lighting Device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2021-10-28 US disclosed
US-20210336156-A1 Organic Compound, Light-Emitting Device, Light-Emitting Apparatus, Electronic Device, and Lighting Device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2021-10-28 US disclosed
CN-112673013-A Organic compound, light-emitting element, light-emitting device, electronic device, and lighting device 株式会社半导体能源研究所 2021-04-16 CN disclosed
WO-2020026106-A1 ORGANIC COMPOUND, LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, ELECTRONIC EQUIPMENT, AND LIGHTING DEVICE 株式会社半導体エネルギー研究所 2020-02-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210336156-A1 Organic Compound, Light-Emitting Device, Light-Emitting Apparatus, Electronic Device, and Lighting Device GRK1, GNA11, GNB1 SLC6A2 4212/4885SLC6A4 4553/4885SLC6A3 4309/4885
US-12563960-B2 Organic compound, light-emitting device, light-emitting apparatus, electronic device, and lighting device INTS9, L1CAM, GRK1 SLC6A2 3909/4885SLC6A4 4547/4885SLC6A3 4180/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.